Biometric Telehealth and the Management of Chronic Pain
Biometric telehealth is a tool that allows chronic pain patients to access evidence-based treatment remotely. Telehealth makes it easier for patients to obtain specialist services and pain rehab programs. It removes the burden of travel on patients with work-related injuries. There is improved communication and continuity of care, ultimately leading to better outcomes. Yet, many patients and physicians remain hesitant to use telehealth platforms because they feel a video consultation simply cannot recreate an office visit.
Biometric Telehealth addresses many of the concerns that individuals have with video- only platforms. It is a comprehensive remote platform that makes the patient-physician interaction an immersive experience, similar to participating in a comprehensive rehabilitation program in the clinic. Employees at a worksite or patients at home undergoing workers’ compensation evaluations can have medical-grade remote exams of the heart, lungs, abdomen, ears, throat, and skin. Providers can do pretty much everything except start an IV! In this article, we discuss some of the advantages of a biometric telehealth platform for patients with chronic pain.
Benefits of Biometric Telehealth for Patients with Chronic Pain
Here are some of the benefits for patients with chronic pain due to conditions such as fibromyalgia, CRPS and RSD:
- Maximizes face-to-face time.
- Provides expert evidence-based biopsychosocial assessment and treatment.
- Allows healthcare provider to view in real-time the patients’ condition and progress.
- Permits the physician to communicate with the patient to provide ongoing treatment and support.
- Allows real-time interaction with the patient’s entire healthcare team.
- Permits medical records to be received and progress reports to be studied before consultation time.
- Maintains patient dignity and privacy.
Conventional pain treatment options available to patients with chronic pain mostly offer short-term, partial pain relief. The biopsychosocial model is a holistic approach to chronic pain management. Whether treatment is delivered in clinic or via the Biometric Telehealth platform, the focus is on functional restoration. This approach helps maintain continuity of care, thus reducing disability and emotional distress and improving quality of life.
Biometric Telehealth Outcomes in Chronic Pain Management
Chronic pain cannot be managed with a one-dimensional medically-oriented approach. It needs a multidisciplinary approach that encompasses a biopsychosocial formulation. The pain management model we follow in the clinic at the Institutes of Health includes biomedical, cognitive, physiological, behavioral, and emotional components. Biometric telehealth makes it possible for us to offer this multi-modality treatment to chronic pain patients remotely.
Biometric Telehealth for Chronic Pain: A Cost Analysis
Biometric Telehealth: A Proactive Approach to Chronic Pain Management
Chronic pain involves both physical and behavioral issues. It is common to encounter patients with coexisting conditions, for example, chronic pain and sleep problems or chronic pain and weight gain. For the best outcomes, providers need to focus on both the physical and psychological aspects of care. In the traditional method of treatment, for example, providers ask patients to fill out a survey during the monthly visit. The patient must jog their memory and describe their symptoms over the previous month. The provider then alters the care plan based on the patient’s recollection.
The Institutes of Health is an industry leader in Biometric Telehealth. We provide a full range of telehealth services for pain treatment, medication management, PTSD, brain injuries, sleep problems and neuropsychological evaluations, both in clinic and through our state-of-the-art biometric telehealth platform. Call us today to learn more about our programs for chronic pain management. They are cost-effective and can significantly improve outcomes for you and your patients.
References
- https://www.ncbi.nlm.nih.gov/pubmed/27838498
- https://clinicaltrials.gov/ct2/show/study/NCT01055639
- https://www.contemporaryclinicaltrials.com/article/S1551-7144(17)30497-4/pdf
- https://clinicaltrials.gov/ct2/show/results/NCT01757301
- https://www.ncbi.nlm.nih.gov/pubmed/19484320
- https://www.ncbi.nlm.nih.gov/pubmed/16691087